Tumor niche network-defined subtypes predict immunotherapy response of esophageal squamous cell cancer
Summary: Despite the promising outcomes of immune checkpoint inhibitors (ICIs), resistance to ICI presents a new challenge. Therefore, selecting patients for specific ICI applications is crucial for maximizing therapeutic efficacy. Herein, we curated 69 human esophageal squamous cell cancer (ESCC) p...
שמור ב:
| Principais autores: | , , , , , , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2024-05-01
|
| סדרה: | iScience |
| נושאים: | |
| גישה מקוונת: | http://www.sciencedirect.com/science/article/pii/S2589004224010174 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
